Release of mitochondrial cytochrome c initiates the apoptosome (a multimeric protein complex) formation leading to caspase activation and apoptosis. We have discovered various mechanisms that regulate apoptosome formation and function in cancer cells.   

Nucleotide regulation of apoptosome formation and function 

Figure from a scientific research study
Click to view larger image

 

We have identified that physiological levels of nucleotides bind cytochrome c, and therefore block the most upstream events in the apoptosome formation (i.e., cytochrome c-Apaf-1 interaction), which inhibits caspase activation and apoptosis. 

We have dissected the important role for lysine residues of cytochrome c and nucleotides in the regulation of apoptosome-dependent apoptotic cell death as well as demonstrate how these mutations and nucleotides may have a pivotal role in understanding human diseases such as cancer.  

Novel regulation of apoptosome by XIAP, Bim, and oxidative phosphorylation (OXPHOS) 

Bim, a proapoptotic BH3-only protein, plays a critical role in Bax/Bak channel formation causing mitochondrial membrane permeabilization and apoptosis. We observed that Bim is highly upregulated in cancer cells and harbors a novel prosurvival function in cancer. 

We identified a novel proapoptotic function of X-linked inhibitor of apoptosis protein (XIAP), which is considered as a prosurvival protein. We observed that global dynamic structural changes of key macromolecules (including proteins, lipids, DNA, and RNAs) during apoptosis at mitochondria represents a new hallmark of apoptosis. We define that restoration of the OXPHOS system is essential for cell death induction.   

New avenues to target mitochondria  

These findings may lead to development of novel anticancer agents targeting novel function of Bim, XIAP, and OXPHOS in cancer. These findings provide avenues to target mitochondria either by single agent or in combination for overcoming resistance and prevention of recurrence of various types of cancer including prostate cancer. 

Related publications 

Connect with the Chandra Lab 

Email: Dhyan.Chandra@RoswellPark.org  
Phone: 716-845-4882 

Department of Pharmacology & Therapeutics 
Roswell Park Comprehensive Cancer Center 
Elm and Carlton Streets 
Buffalo, NY 14263